Regulations and Guidance From the Federal Government
- CDC Homepage for COVID-19
- CDC Guidance for Healthcare Professionals
- CMS Waivers & Flexibilities
- FAQ: CMS Waivers & Flexibilities and the End of the COVID-19 Public Health Emergency [PDF]
- CMS Coronavirus (COVID-19) Partner Toolkit
- Updates to DEA Guidance and Flexibility During COVID-19 Pandemic [PDF]
- FDA COVID-19 Resources
- FDA Emergency Use Authorizations
- HRSA COVID-19 Uninsured Program Portal
- OSHA COVID-19 Resources From the Occupational Safety and Health Administration
- Telehealth.hhs.gov - Central source of information on telehealth resources and tools for patients and providers
State and Other Regulatory Guidance
- Links to State Boards of Pharmacy from the National Association of Boards of Pharmacy (NABP)
- USP Operational Considerations for Sterile Compounding During COVID-19 Pandemic